Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

17.01EUR
5 Dec 2016
Change (% chg)

€-0.52 (-2.99%)
Prev Close
€17.72
Open
€17.50
Day's High
€17.67
Day's Low
€16.97
Volume
1,792,241
Avg. Vol
712,544
52-wk High
€22.45
52-wk Low
€16.97

Select another date:

Tue, Nov 8 2016

BRIEF-Grifols 9-month net profit rises to 406.1 mln euros

* 9-month net profit 406.1 million euros ($448.5 million)versus 401.6 million euros year ago

BRIEF-Oncbiomune signs term sheet to acquire Vitel Laboratorios, S.A. De C.V.

* Oncbiomune signs term sheet to acquire Vitel Laboratorios, s.a. De c.v. Source text for Eikon: Further company coverage:

BRIEF-Grifols to pay FY 2016 interim dividend of 0.18 euro/shr

* Says to pay interim dividend for 2016 of 0.18 euro ($0.1972) per share on Dec. 7 Source text for Eikon: Further company coverage: ($1 = 0.9127 euros) (Gdynia Newsroom)

BRIEF-Medica Sur receives green light to buy LMP

* Said on Wednesday received an approval from a competition watchdog to acquire Laboratorio Medico Polanco (LMP) and its units Laboratorios Clinicos de Puebla (LCP), Laboratorios Clinicosde Puebla en Bioequivalencia (LCPB) and other units

BRIEF-Prim buys branches from Laboratorios Milo for fixed price of 1.2 mln euros

* Buys pharmacy, orthopedics and podiatry branches from Laboratorios Milo for 1.24 million euros ($1.39 million) and variable price depending on results of the branches in 2016-2020 Source text for Eikon:

BRIEF-Grifols' phase I Alzheimer vaccine study shows good safety profile, tolerability

* Says unit Araclon Biotech presents phase I Alzheimer vaccine results showing good safety profile and tolerability

BRIEF-Grifols reports H1 EBITDA at 553.6 mln euros

* H1 net profit 264.4 million euros ($293.1 million) versus 256 million euros in Reuters poll

BRIEF-Grifols to buy a 48,000 square meter plot of land

* To buy a plot of 48,716 square meters to expand its production facilities in Barcelona

BRIEF-SGS buying Laboratorios Contecon Urbar

* Says it's buying Laboratorios Contecon Urbar with operations in Colombia and Panama.

BRIEF-Prim says price of the deal with Laboratorios Milo is not defined

* Says acquisition price of the branches of Laboratorios Milo SA will not be established until the end of negotiations, with the date scheduled for Sept 1

Select another date: